Gentherm (THRM) schedules Rule 144 resale of 4,700 common shares via Merrill Lynch
Gentherm Inc. (THRM) has filed a notice under Rule 144 to sell up to 4,700 shares of its common stock through Merrill Lynch on NASDAQ, with a noted transaction date of July 29, 2026. The filing also details prior stock plan activities, including share acquisitions on July 1, 2022, March 12, 2023, and March 22, 2023. This indicates a proposed resale of existing shares, not a new issuance, allowing previously restricted securities to enter the public market.
Gentherm Number of Employees 2026 | Employee Count & Headcount Data
Gentherm, Inc. (THRM) has approximately 14,153 employees globally as of March 2026, representing a 4.9% growth from 2023. The company is actively hiring with 60 job postings in 2026, though new postings per month have cooled. Employee sentiment is reported as negative and declining.
Gentherm (NASDAQ: THRM) grows revenue and advances $1B Modine merger
Gentherm (NASDAQ: THRM) reported increased product revenues of $416.166 million in Q2 2026, up from $375.090 million a year earlier, with net income rising to $4.420 million. The company is advancing its $1 billion Reverse Morris Trust merger with Modine’s Performance Technologies business, expected to close by early Q4 2026, and recently acquired Innovative Medical Equipment for $34 million. Despite increased operating expenses and debt, Gentherm's automotive segment drove growth, and it has authorized a new $400 million stock repurchase program.
Gentherm Inc (THRM) Stock Price | Live Quotes & Charts | NASDAQ
This page provides live quotes and charts for Gentherm Inc (THRM) stock, showing its current trading price and recent performance. It also includes sections for analyst ratings and earnings information, although data for these sections is currently unavailable. The article is part of a financial education website and features disclaimers about the risks associated with stock trading, particularly day trading.
THRM SEC Filings - Gentherm 10-K, 10-Q, 8-K Forms
This page provides a comprehensive overview of Gentherm's (THRM) SEC filings, including annual, quarterly, and material event reports, as well as insider trading forms. It features AI-generated summaries, impact scoring, and sentiment analysis for each filing. Recent filings highlight passive investment disclosures, a new $550M credit facility, and details concerning its proposed merger with Modine Manufacturing Company's Performance Technologies business.
Gentherm acquires Innovative Medical Equipment to expand medical portfolio
Gentherm (NASDAQ: THRM) has acquired Innovative Medical Equipment, LLC (IME), a Cleveland-area provider of the ThermaZone thermal therapy device. This acquisition is a strategic move to strengthen Gentherm's Medical business and expand its product portfolio, although the financial terms of the transaction were not disclosed. The integration of IME's ThermaZone device aligns with Gentherm's broader strategy to diversify its product range and leverage its expertise in thermal management technologies within the medical sector.
Gentherm (THRM) Jumps As Medical Push And Analyst Upgrades Align
Gentherm Inc. (THRM) shares surged over 26% due to several converging catalysts, including FDA 510(k) clearance for its ThermAffyx Patient Safety System and the acquisition of Innovative Medical Equipment. Analysts from Stifel and JPMorgan subsequently raised their price targets, indicating bullish sentiment on Gentherm's strategic expansion into the medical technology sector beyond its core automotive business. The company's financial performance shows modest profitability, with growth expectations driving its current valuation.
Gentherm (NASDAQ: THRM) lifts 2026 guidance and authorizes $400M buyback
Gentherm reported strong second-quarter 2026 results, with product revenues up 11.0% year over year and adjusted diluted EPS increasing to $0.75. The company raised its full-year 2026 guidance for product revenues, adjusted EBITDA, and adjusted free cash flow, reflecting confidence in its performance. Additionally, Gentherm's board authorized a new three-year stock repurchase program of up to $400 million, replacing the previous one, and confirmed its planned combination with Modine Performance Technologies is on track.
Gentherm Inc $THRM Shares Bought by Bessemer Group Inc.
Bessemer Group Inc. significantly increased its stake in Gentherm Inc. (NASDAQ:THRM) during the first quarter by 50.5%, acquiring an additional 43,500 shares. The auto parts company also reported strong first-quarter earnings, beating analyst estimates for both EPS and revenue, with revenue rising 11.2% year-over-year. Despite mixed analyst ratings, the consensus remains a Hold with a target price of $38.60.
Gentherm gets FDA clearance for ThermAffyx™, a new patient warming and securement system for robotic surgeries.
Gentherm Inc. has received FDA 510(k) clearance for its ThermAffyx™ Patient Safety System, a Class II medical device designed for patient warming and securement during robotic-assisted surgeries. This innovative system aims to address challenges such as hypothermia and patient movement, especially in the Trendelenburg position. Clinical trials are set to begin in August 2026, with commercial sales anticipated in Q3 2026, expanding Gentherm's medical product offerings in patient temperature management.
Gentherm receives FDA clearance for ThermAffyx Patient Safety System
Gentherm received FDA 510(k) clearance for its ThermAffyx Patient Safety System, a Class II medical device designed for robotic-assisted surgeries. This innovative system combines active patient warming, securement, and pressure reduction, addressing critical safety gaps in millions of procedures annually. Product trials are set to begin in August, with revenue generation anticipated in Q3 2026.
Gentherm's Cleared Device Combines Warming and Securement for Robotic Surgery
Gentherm (THRM) announced FDA 510(k) clearance for its ThermAffyx™ Patient Safety System, a Class II medical device designed for robotic-assisted surgeries. This innovative system integrates active underbody warming, securement, and pressure reduction, addressing the challenges of patient hypothermia in procedures like the Trendelenburg position. Product trials are set for August, with revenue generation anticipated by Q3 2026.
Gentherm Medical wins FDA clearance for ThermAffyx patient safety system
Gentherm Medical has received FDA 510(k) clearance for its ThermAffyx patient safety system, a Class II device designed for robotic-assisted surgery. Product trials are scheduled to commence in August, with revenue generation expected to begin in the third quarter of 2026. This news brief was generated by Public Technologies using AI based on content originally published by Gentherm Inc. via GlobeNewswire.
Hillsdale Investment Management Inc. Increases Stake in Gentherm Inc $THRM
Hillsdale Investment Management Inc. significantly increased its stake in Gentherm Inc. (NASDAQ:THRM) by 639.3% in the first quarter, now owning 206,446 shares valued at $5.7 million. This move highlights broad institutional interest, with hedge funds and other institutions collectively holding 97.13% of Gentherm's stock. The company also reported better-than-expected Q1 results, with $0.84 EPS on $393.71 million in revenue, while analysts maintain a consensus "Hold" rating and a price target of $37.40.
[SCHEDULE 13G] Gentherm Inc Passive Investment Disclosure (>5%)
Dimensional Fund Advisors LP has reported a passive investment in Gentherm Inc, holding 1,568,291 shares, which represents 5.1% of the common stock. This disclosure is a SCHEDULE 13G filing, indicating that Dimensional Fund Advisors LP acts as an investment adviser to various funds and disclaims beneficial ownership, with no individual fund exceeding 5% ownership. The filing highlights their sole voting power over 1,533,172 shares and sole dispositive power over 1,568,291 shares.
Analysts Have Conflicting Sentiments on These Consumer Cyclical Companies: Five Below (FIVE), Bayerische Motoren Werke Aktiengesellschaft (OtherBAMXF) and Gentherm (THRM)
This article summarizes analyst sentiments on three consumer cyclical companies: Five Below (FIVE), Bayerische Motoren Werke Aktiengesellschaft (BAMXF), and Gentherm (THRM). Five Below received a Hold rating from Bernstein with a Moderate Buy consensus. Bayerische Motoren Werke Aktiengesellschaft maintained a Buy rating from Bernstein, also with a Moderate Buy consensus. Gentherm received a Buy rating from Stifel Nicolaus, aligning with a Moderate Buy consensus from analysts.
Gentherm Announces Participation in Upcoming Second Quarter 2026 Investor Conference
Gentherm (NASDAQ: THRM) has announced its participation in several investor conferences during the second quarter of 2026. This includes a fireside chat at the Baird Global Consumer, Technology & Services Conference and attendance at the Stifel Cross Sector 1x1 Conference and Wells Fargo Industrials & Materials Conference. The company's President and CEO along with the EVP of Finance and CFO will speak at these events, providing an opportunity for analysts and investors to engage with Gentherm's leadership.
Gentherm (NASDAQ: THRM) holders approve 1.7M-share equity plan increase
Gentherm Incorporated shareholders have approved an amendment to its 2023 Equity Incentive Plan, increasing the maximum number of common shares that can be issued under the plan by 1.7 million. This expansion adds to the original 3.73 million-share base pool. Additionally, shareholders at the annual meeting elected nine directors, approved executive compensation on an advisory basis, and ratified Ernst & Young LLP as the independent auditor for 2026.
[425] Gentherm Inc Business Combination Communication | THRM SEC Filing - Form 425
Gentherm Inc. shareholders approved an amendment to the 2023 Equity Incentive Plan, increasing the share limit by 1,700,000 shares to an aggregate ceiling of 5,430,000 shares. This approval happened at their annual meeting on May 14, 2026, where directors were also elected, executive compensation was approved on an advisory basis, and Ernst & Young LLP was ratified as the independent auditor. The company also disclosed a proposed transaction involving Gentherm, Modine, and SpinCo, with related SEC filings expected.
Gentherm (THRM) director Heinzmann granted 4,292 restricted shares as board compensation
Gentherm (THRM) director David W. Heinzmann was granted 4,292 shares of Restricted Common Stock on May 14, 2026, as compensation for his service on the company’s Board of Directors. This award, made under Gentherm’s 2023 Equity Incentive Plan, was at no cash cost per share. Following this grant, Heinzmann directly holds a total of 21,365 shares of Gentherm common stock, with the transaction being a routine, compensation-related stock award rather than an open-market purchase or sale.
Gentherm (THRM) director receives 4,292 restricted shares as board compensation
Gentherm director Stacey John was granted 4,292 restricted common shares on May 14, 2026, as compensation for board service under the company's 2023 Equity Incentive Plan. These shares were awarded at a stated price of $0.00 per share, increasing John's direct holdings in Gentherm to 27,112 shares. This transaction was reported in a Form 4 filing, indicating an internal acquisition rather than an open-market purchase.
Gentherm (THRM) director Kenneth Washington receives 4,292 restricted shares grant
Gentherm Inc. director Kenneth E. Washington was granted 4,292 restricted common shares as compensation for his service on the company's Board of Directors. This award, issued under Gentherm's 2023 Equity Incentive Plan, increased his direct holdings to 15,257 common shares. The transaction, reported in a Form 4 filing, is an equity award and not an open-market purchase, and its impact is considered neutral.
Gentherm (THRM) Beats Q1 Earnings and Revenue Estimates
Gentherm (THRM) reported Q1 earnings of $0.84 per share, significantly surpassing the Zacks Consensus Estimate of $0.53, and revenues of $393.71 million, beating estimates by 9.07%. Despite this strong performance, the company's shares have declined by 21% year-to-date, and its Zacks Rank is currently a #4 (Sell) due to unfavorable estimate revisions. Another industry peer, Aeva Technologies, Inc. (AEVA), is expected to report its Q1 results soon.
Vanguard discloses 1.83M Gentherm shares (THRM) ownership (5.99%)
Vanguard Portfolio Management has disclosed beneficial ownership of 1,829,216 shares of Gentherm Inc. (THRM), representing 5.99% of the common stock. This Schedule 13G filing indicates a passive investment, with Vanguard having sole dispositive authority over all shares and sole voting power over 25,210 shares, consistent with an asset manager's role rather than an activist intent. The filing specifies that these holdings include shares managed for Vanguard funds and client accounts.
Gentherm Reports 2026 First Quarter Results
Gentherm (NASDAQ:THRM) reported strong first-quarter 2026 financial results, with significant revenue growth of 7.2% (excluding foreign exchange impacts) and record quarterly revenue of $394 million. The company also announced a transformational combination with Modine Performance Technologies, which is on track to close in 2026. Gentherm's gross margin expanded year-over-year, and it secured $395 million in Automotive New Business Awards, demonstrating improved performance and strategic growth initiatives.
Record Q1 for Gentherm (NASDAQ: THRM) as Modine combo advances
Gentherm (NASDAQ: THRM) reported record Q1 2026 product revenues of $393.7 million, an 11.3% increase year-over-year, alongside improved profitability with adjusted EBITDA up to $49.3 million. The company reaffirmed its full-year 2026 guidance and continues to advance its planned combination with Modine Performance Technologies, which is expected to close by the end of the year. Gentherm's strong financial position includes $455.5 million in liquidity and low net leverage.
Gentherm Reports 2026 First Quarter Results
Gentherm (NASDAQ: THRM) announced strong financial results for the first quarter ended March 31, 2026, including record quarterly revenue of $394 million, up 7.2% year-over-year excluding foreign exchange, and expanded gross margin. The company also confirmed its planned transformational combination with Modine Performance Technologies is on track to close in 2026, aiming to create a leader in thermal and precision flow management. Gentherm secured $395 million in new automotive business awards and reiterated its full-year 2026 guidance for product revenues and Adjusted EBITDA.
(THRM) Gentherm Expects 2026 Product Revenue Range $1.5B - $1.6B, vs. FactSet Est of $1.54B
Gentherm Incorporated (THRM) announced its product revenue expectations for 2026, projecting a range of $1.5 billion to $1.6 billion. This forecast is in comparison to FactSet's estimate of $1.54 billion. The news was published on the same day the company reported its first-quarter earnings for 2026.
Earnings Flash (THRM) Gentherm Incorporated Reports Q1 Revenue $393.7M, vs. FactSet Est of $362.2M
Gentherm Incorporated (THRM) announced its Q1 revenue reached $393.7 million, surpassing FactSet's estimated $362.2 million. The company also reported Q1 adjusted EPS of $0.84 per share, exceeding the FactSet estimate of $0.51. Gentherm expects its 2026 product revenue to be in the range of $1.5 billion to $1.6 billion.
GENTHERM ($THRM) Releases Q1 2026 Earnings
GENTHERM ($THRM) announced its Q1 2026 earnings, reporting $0.84 per share, significantly beating analyst estimates. The company's revenue also exceeded expectations. Following the earnings release, an overview of hedge fund activity and recent analyst ratings and price targets for THRM is provided.
Gentherm (NASDAQ: THRM) files 8-K/A on credit agreement amendment
Gentherm Incorporated filed an amended current report (8-K/A) to correct a clerical error in the signatory for Gentherm (Texas), Inc. on the First Amendment to its Second Amended and Restated Credit Agreement. The amendment clarifies that the underlying credit agreement terms and the original current report remain unchanged, focusing solely on the signatory correction. The filing also includes standard disclosures regarding a proposed transaction involving Gentherm, Modine Manufacturing Company, and SpinCo, emphasizing the need for investors to review related SEC filings.
Gentherm, Inc. Opens with a 5.25% Gain, Outperforming S&P 500's 2.51% Increase
Gentherm, Inc. opened today with a 5.25% gain, outperforming the S&P 500's 2.51% increase, despite recent financial challenges including declining net sales and profits for the last two quarters. The company's valuation metrics appear elevated compared to peers, and its stock has underperformed the S&P 500 over the past year. This opening gain represents a momentary positive shift amid a mixed short-term trend for the small-cap auto components and equipment player.
Gentherm Inc (NASDAQ:THRM) Given Average Recommendation of "Hold" by Brokerages
Gentherm Inc (NASDAQ:THRM) has received a consensus "Hold" rating from seven analysts, with an average 12-month price target of $39.40. Recent analyst actions include downgrades and price target reductions reflecting mixed sentiment following the company's Q4 earnings miss, despite revenue beating estimates. Institutional investors hold approximately 97% of the stock, with several funds increasing their positions.
Gentherm, Inc. Experiences Revision in Stock Evaluation Amid Mixed Performance Indicators
Gentherm, Inc., a small-cap auto components company, has recently had its stock evaluation revised due to mixed performance indicators. The stock price has declined, trading at $27.67, and its performance has lagged behind the S&P 500 across various timeframes, including a significant year-to-date return deficit. Technical indicators show a mixed outlook, with some bullish signals like RSI, alongside bearish trends indicated by MACD, Bollinger Bands, and Dow Theory.
The Vanguard Group lists zero Gentherm holdings (NASDAQ: THRM)
The Vanguard Group has filed an amended Schedule 13G/A, reporting zero beneficial ownership of Gentherm Inc. common stock (THRM). This change is attributed to an internal realignment on January 12, 2026, which led to certain subsidiaries reporting their holdings separately under SEC Release No. 34-39538. The filing clarifies that this re-statement is a procedural change in reporting structure rather than an indication of a new market trade or sale of shares by Vanguard.
Gentherm (THRM) CAO gets stock award, some shares withheld for tax
Gentherm's Chief Accounting Officer, Nicholas Breisacher, received 353 shares of common stock from the vesting of performance-based restricted stock units (PSUs) granted in 2023. These PSUs settled based on adjusted EBITDA and ROIC performance targets. To cover tax obligations, 102 shares were withheld, increasing his direct holdings to 5,789 Gentherm common shares.
Gentherm (THRM) SVP Barbara Runyon nets equity award after PSU vesting
Barbara J. Runyon, SVP and CHRO of Gentherm Inc., received an equity award of 2,121 shares of common stock after performance-based restricted stock units (PSUs) vested. These shares were granted at no cost, and 961 shares were withheld at $28.64 each to cover tax obligations. The PSU payout was determined by the company's adjusted EBITDA and ROIC performance against targets set in 2023.
Gentherm (THRM) SVP granted shares as PSUs vest; 607 withheld for tax
Gentherm Inc.'s Senior Vice President, Rafael Barkas, received 2,121 shares of common stock as a result of performance-based restricted stock units (PSUs vesting). To cover tax obligations, 607 shares were withheld at $28.64 per share. After these transactions, Barkas directly owns 31,893 shares of Gentherm common stock, with the PSU payout determined by adjusted EBITDA and ROIC performance metrics.
Gentherm, Inc. Experiences Revision in Its Stock Evaluation Amid Mixed Performance Indicators
Gentherm, Inc., a small-cap auto components company, has seen a stock price decline and underperformed the S&P 500 over the past year and year-to-date. Technical indicators present a mixed picture, with bearish signals from MACD and Bollinger Bands balancing bullish RSI trends. The company's current stock price is $27.86, and its negative returns emphasize the need for strategic adjustments to improve its market position.
Gentherm (THRM) SVP Barkas receives 7,665 RSU equity grant in Form 4
Gentherm Inc.'s Senior Vice President, Rafael Barkas, was granted 7,665 Restricted Stock Units (RSUs) under the company's 2023 Equity Incentive Plan. These RSUs will vest in three equal installments on March 17, 2027, March 17, 2028, and March 17, 2029. Following this grant, Barkas directly holds 30,379 shares of Gentherm common stock, with this award serving as compensation rather than an open-market transaction.
Gentherm Launches Enhanced Comfort Solutions in Partnership with KUKA Home in Asia
Gentherm has expanded its thermal management technology beyond automotive applications into home furniture through a new partnership with KUKA Home in Asia, branded "Enhanced Comfort by Gentherm." This collaboration leverages Gentherm's expertise to quickly adapt and deploy proven comfort technologies for broader markets, enhancing consumer experiences in KUKA Home's products. The move signifies Gentherm's strategic initiative to enter new growth markets, demonstrating the scalability and versatility of its innovations.
Auto comfort tech moves into sofas as Gentherm launches with KUKA
Gentherm (NASDAQ: THRM) has announced its expansion into the home furniture market through a collaboration with KUKA Home in Asia. This partnership will integrate Gentherm's thermal and pneumatic comfort technologies, previously exclusive to the automotive sector, into home furniture products under the co-branded program "Enhanced Comfort by Gentherm." The move demonstrates the scalability of Gentherm's technology into new applications and aligns with the company's recent strategic developments in automotive and medical sectors.
Gentherm (NASDAQ: THRM) revises equity awards, notes Modine deal
Gentherm (NASDAQ: THRM) has updated its 2023 Equity Incentive Plan by revising its restricted stock unit and performance stock unit agreements. These revisions, approved by the Compensation and Talent Committee, include provisions for accelerated vesting in cases of death, disability, certain involuntary terminations, and qualifying retirements. Additionally, the company referenced a planned transaction involving Gentherm, Modine, and Modine’s Performance Technologies business (SpinCo), indicating that relevant SEC filings (Form S-4 and Form 10) will be prepared to provide shareholders with prospectus and proxy information.
Gentherm, Inc. Forms Death Cross, Signaling Potential Bearish Trend Ahead
Gentherm, Inc. has formed a Death Cross, suggesting a potential bearish trend, even though some technical indicators show mixed signals. The company has significantly underperformed the S&P 500 over the past year, with its stock down 7.77%, and is down 22.93% year-to-date. Investors are advised to monitor these trends due to anticipated volatility.
American Century Companies Inc. Grows Position in Gentherm Inc $THRM
American Century Companies Inc. significantly increased its stake in Gentherm Inc (NASDAQ:THRM) by 36.1% in the third quarter, now owning 513,791 shares valued at $17.5 million. Despite missing EPS estimates, Gentherm exceeded revenue expectations with an 8.5% year-over-year increase. Analysts hold a mixed view on the stock, with an average "Hold" rating and a price target of $40.40, while the stock currently trades around $28.91.
New surgery system to warm and secure patients in one device
Gentherm Medical has appointed KNB Communications as its agency of record to launch the ThermAffyx™ Patient Safety System, a novel device designed to integrate patient warming and securement during surgery. The system has a 510(k) Class II premarket notification submitted to the FDA, with clearance expected in May 2026. KNB Communications will focus on strategic healthcare communications to raise awareness among clinicians, investors, and patients ahead of its commercial rollout.
Gentherm Medical Selects KNB Communications to Amplify News of its Groundbreaking Patient Warming and Securement Device
Gentherm, a global leader in thermal management technologies, has partnered with KNB Communications, a healthcare marketing agency, to promote its new ThermAffyx™ Patient Safety System. This innovative medical device aims to address both patient warming and securement during surgery. FDA clearance for the ThermAffyx™ system is anticipated in May.
Gentherm Medical Selects KNB Communications to Amplify News of its Groundbreaking Patient Warming and Securement Device
Gentherm, a leader in thermal management technologies, has partnered with KNB Communications to launch its new ThermAffyx™ Patient Safety System. This integrated medical device aims to solve both patient warming and securement challenges during surgery. FDA clearance for the device is anticipated in May after Gentherm submitted a 510(k) Class II premarket notification earlier this year.
Gentherm, Inc. Experiences Revision in Stock Evaluation Amidst Market Challenges
Gentherm, Inc., a small-cap company in the Auto Components & Equipment sector, has seen a stock price decline and underperformed the S&P 500 over the past year. Technical indicators for the stock show mixed signals, reflecting ongoing challenges in a competitive market environment. The company's returns over different time frames highlight significant underperformance compared to the S&P 500.
Vanguard Group Inc. Has $112.50 Million Stock Position in Gentherm Inc $THRM
Vanguard Group Inc. reduced its stake in Gentherm Inc. (NASDAQ:THRM) by 1.7% in the third quarter, holding 3,302,983 shares valued at approximately $112.5 million. Despite other institutional investors increasing their positions, Vanguard's move means institutional investors now collectively own about 97.13% of Gentherm. The company reported Q3 EPS of $0.49, missing consensus estimates but revenue beat expectations, rising 8.5% year-over-year.
